Therapy according to the Polish Adult Leukaemia Group ALL-7 protocol (PALG ALL-7) was started in October 2022 [daunorubicine 83.5 mg—day 1, 8, 15, 22, vincristine 2.0 mg—day 1, 8, 15, 22, cytarabine 40.0 mg—day 13, 27, PEG-asparaginase (Spectrile®) 3.340 UI—day 20, methotrexate 15.0 mg—day 13, 27] [9]. Here, ASPG is linked to acute lymphoblastic leukemia.